Markus Haindl

Global Head Gene Therapy Technical Research & Development at Roche-Genentech

Speaker

After Studying Biology at the University of Regensburg, Markus finished his PhD in 2008 in Molecular Cell Biology at the Max-Planck-Institute of Biochemistry in Munich investigating regulation of the posttranslational modifier SUMO and it’s involvement in Ribosome Biogenesis and Cellcycle. He subsequently joined McKinsey&Company as a consultant taking over international strategy and operations projects for clients within the Pharma, Biotech and High-Tech industry.

By the end of 2010 Markus joined Roche at the Biotech Centre in Penzberg. Since then he was working as a Groupleader and Department Head in Bioprocess Development as well as Analytical Development & New Technologies before he took over the Lead for Roche’s efforts towards Technical Development for in vivo Gene Therapies now serving as the Global Head Gene Therapy Technical Research & Development.